Christopher Kaster is listed as a director on 4 SEC Form D filings by 1 issuer between May 2020 and Jan 2025: Alleviant Medical, Inc. (Austin, TX — other health care — 2020–2025; $90.8M reported sold to 35 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Adam Berman (4 shared filings), Maria Berkman (4 shared filings), Kirk Nielsen (3 shared filings), Ashok Gowda (2 shared filings), Brian R. Smith (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Christopher Kaster and found 10 differences: Bankruptcy case: First National Bank Of Giddings v. Kriegel; Form D filed 39 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.